Avalon Trust Co Cuts Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Avalon Trust Co decreased its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 0.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 285,375 shares of the company’s stock after selling 2,200 shares during the period. VanEck Pharmaceutical ETF makes up 2.1% of Avalon Trust Co’s portfolio, making the stock its 14th biggest position. Avalon Trust Co owned 0.05% of VanEck Pharmaceutical ETF worth $23,220,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Conservest Capital Advisors Inc. purchased a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $447,000. Private Client Services LLC purchased a new position in VanEck Pharmaceutical ETF in the 4th quarter valued at about $298,000. International Assets Investment Management LLC grew its stake in shares of VanEck Pharmaceutical ETF by 910.0% during the fourth quarter. International Assets Investment Management LLC now owns 27,502 shares of the company’s stock valued at $2,238,000 after acquiring an additional 24,779 shares in the last quarter. Investment Partners Asset Management Inc. acquired a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at about $354,000. Finally, Allworth Financial LP purchased a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter worth about $28,000.

VanEck Pharmaceutical ETF Price Performance

PPH traded down $0.30 on Friday, reaching $87.11. The company’s stock had a trading volume of 111,114 shares, compared to its average volume of 140,129. VanEck Pharmaceutical ETF has a 1 year low of $74.05 and a 1 year high of $91.16. The business’s 50 day moving average is $88.43 and its 200 day moving average is $83.92. The stock has a market cap of $500.01 million, a price-to-earnings ratio of 20.57 and a beta of 0.72.

VanEck Pharmaceutical ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.5328 per share. The ex-dividend date of this dividend was Monday, April 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.